Effects of morinda officinalis oligoseon on plasma levels of BDNF, GDNF, VEGF and IGF-1 in depressed patients

Shuo DENG,Wei-feng MI,Yi XU,Zhi-meng LI,Hai-tao JIA,Xin-long TANG,Ling-zhi LI,Li-hua GUO,Ying SHI,Hong-yan ZHANG
2017-01-01
Abstract:Objective:To investigate the effects of morinda officinalis oligose on plasma levels of BDNF,GDNF,VEGF and IGF-1 in depressed patients.Methods:This study included 32 patients with in mild to moderate depression(ICD-10 critreia).After entering the group,the patients were provided with antidepressant treatment with single Bajitian oligosaccharide capsule,being visited every two weeks to keep a record of depressive symptoms and medication.There are a total of 8 weeks of treatment in each group.And blood samplings are taken before and after the treatment.The BDNF GDNF,VEGF,IGF-1 levels are tested by ELISA adsorption methods,and Hamilton Depression Scale (HAMD-17) is employed to assess the patients' depression level.Results:After 8 weeks' treatment the HAMD-17 scores and each factor scores declined significantly compared with 0 week (W0) (P <0.01),the plasma levels of VEGF significantly declined (Z =-2.354,P < 0.05),the levels of BDNF and GDNF significantly increased (Z=-4.157,P <0.01) (Z =-4.345,P <0.01),and the levels of IGF-1 was not significantly different with 0 week (Z =-0.901,P >0.05).The changes of plasma BDNF and GDNF levels were positively correlated with HAMD-17 reduction ratios (r =0.782,P < 0.01;r =0.456,P < 0.05),but no correlation was observed between VEGF and IGF-1 change ratio and HAMD-17 reduction ratio(r =-0.06,P > 0.05;r =0.039,P > 0.05).Conclusion:Morinda officinalis oligose can improve abnormal levels of BDNF,GDNF and VEGF,but has no effect on IGF-1 level.
What problem does this paper attempt to address?